No abstract available
Keywords:
Cutaneous squamous cell carcinoma; JAK inhibitors; Prognosis; Ruxolitinib.
MeSH terms
-
Carcinoma, Squamous Cell* / drug therapy
-
Humans
-
Nitriles
-
Pyrazoles / adverse effects
-
Pyrimidines
-
Signal Transduction
-
Skin Neoplasms* / drug therapy
Substances
-
Nitriles
-
Pyrazoles
-
Pyrimidines
-
ruxolitinib